These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

274 related items for PubMed ID: 20018200

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Cognitive and motor effects of dopaminergic medication withdrawal in Parkinson's disease.
    Fern-Pollak L, Whone AL, Brooks DJ, Mehta MA.
    Neuropsychologia; 2004; 42(14):1917-26. PubMed ID: 15381022
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Basal ganglia, dopamine and temporal processing: performance on three timing tasks on and off medication in Parkinson's disease.
    Jones CR, Malone TJ, Dirnberger G, Edwards M, Jahanshahi M.
    Brain Cogn; 2008 Oct; 68(1):30-41. PubMed ID: 18378374
    [Abstract] [Full Text] [Related]

  • 8. Motor procedural learning in Parkinson's disease.
    Muslimovic D, Post B, Speelman JD, Schmand B.
    Brain; 2007 Nov; 130(Pt 11):2887-97. PubMed ID: 17855374
    [Abstract] [Full Text] [Related]

  • 9. Action naming in Parkinson's disease patients on/off dopamine.
    Herrera E, Cuetos F.
    Neurosci Lett; 2012 Apr 04; 513(2):219-22. PubMed ID: 22387157
    [Abstract] [Full Text] [Related]

  • 10. Multisensory determinants of orientation perception in Parkinson's disease.
    Barnett-Cowan M, Dyde RT, Fox SH, Moro E, Hutchison WD, Harris LR.
    Neuroscience; 2010 Jun 02; 167(4):1138-50. PubMed ID: 20206672
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Parkinson's disease duration determines effect of dopaminergic therapy on ventral striatum function.
    MacDonald AA, Monchi O, Seergobin KN, Ganjavi H, Tamjeedi R, MacDonald PA.
    Mov Disord; 2013 Feb 02; 28(2):153-60. PubMed ID: 23165957
    [Abstract] [Full Text] [Related]

  • 15. Effects of dopaminergic treatment on bladder function in Parkinson's disease.
    Winge K, Werdelin LM, Nielsen KK, Stimpel H.
    Neurourol Urodyn; 2004 Feb 02; 23(7):689-96. PubMed ID: 15382192
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Differential effects of dopaminergic medication on basic motor performance and executive functions in Parkinson's disease.
    Michely J, Barbe MT, Hoffstaedter F, Timmermann L, Eickhoff SB, Fink GR, Grefkes C.
    Neuropsychologia; 2012 Aug 02; 50(10):2506-14. PubMed ID: 22776611
    [Abstract] [Full Text] [Related]

  • 18. Reversal learning in Parkinson's disease depends on medication status and outcome valence.
    Cools R, Altamirano L, D'Esposito M.
    Neuropsychologia; 2006 Aug 02; 44(10):1663-73. PubMed ID: 16730032
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.